000 | 01946 a2200541 4500 | ||
---|---|---|---|
005 | 20250514060727.0 | ||
264 | 0 | _c20030325 | |
008 | 200303s 0 0 eng d | ||
022 | _a0091-6749 | ||
024 | 7 |
_a10.1067/mai.2003.102 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrugnolo, Francesca | |
245 | 0 | 0 |
_aThe novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells. _h[electronic resource] |
260 |
_bThe Journal of allergy and clinical immunology _cFeb 2003 |
||
300 |
_a380-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAllergens |
650 | 0 | 4 |
_aAmpicillin _xadverse effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, Dermatophagoides _ximmunology |
650 | 0 | 4 | _aArthropod Proteins |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCysteine Endopeptidases |
650 | 0 | 4 |
_aCytokines _xbiosynthesis |
650 | 0 | 4 |
_aDrug Hypersensitivity _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypersensitivity, Immediate _ximmunology |
650 | 0 | 4 |
_aImidazoles _xpharmacology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aInterferon-gamma _xbiosynthesis |
650 | 0 | 4 | _aModels, Immunological |
650 | 0 | 4 |
_aT-Lymphocyte Subsets _xdrug effects |
650 | 0 | 4 |
_aTh1 Cells _xdrug effects |
650 | 0 | 4 |
_aTh2 Cells _xdrug effects |
700 | 1 | _aSampognaro, Salvatore | |
700 | 1 | _aLiotta, Francesco | |
700 | 1 | _aCosmi, Lorenzo | |
700 | 1 | _aAnnunziato, Francesco | |
700 | 1 | _aManuelli, Cinzia | |
700 | 1 | _aCampi, Paolo | |
700 | 1 | _aMaggi, Enrico | |
700 | 1 | _aRomagnani, Sergio | |
700 | 1 | _aParronchi, Paola | |
773 | 0 |
_tThe Journal of allergy and clinical immunology _gvol. 111 _gno. 2 _gp. 380-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1067/mai.2003.102 _zAvailable from publisher's website |
999 |
_c12386568 _d12386568 |